Prospective Studies (cohort, longitudinal, incidence studies) Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public.

Slides:



Advertisements
Similar presentations
Principles of Epidemiology Lecture 10 Dona Schneider, PhD, MPH, FACE
Advertisements

Cohort Studies.
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
Unit 14: Measures of Public Health Impact.
What type of study is this?
Understanding real research 3. Assessment of risk.
Case-Control Study Chunhua Song Warm up.
Cohort Studies.
Manish Chaudhary BPH, MPH
Principles of Epidemiology Lecture 9 Dona Schneider, PhD, MPH, FACE
COHORT STUDY DR. A.A.TRIVEDI (M.D., D.I.H.) ASSISTANT PROFESSOR
Dr K N Prasad MD., DNB Community Medicine
Epidemiological Study Designs And Measures Of Risks (2) Dr. Khalid El Tohami.
Cohort Studies Dr. Amna Rehana Siddiqui & Prof Awatif Alam Prof Ashry Gad Department of Family & Community Medicine September 2013.
HEAPHY 1 & 2 DIAGNOSTIC James HAYES Fri 30 th Aug 2013 Session 2 / Talk 4 11:33 – 12:00 ABSTRACT To estimate population attributable risks for modifiable.
Understanding study designs through examples Manish Chaudhary MPH (BPKIHS)
Biology in Focus, HSC Course Glenda Childrawi, Margaret Robson and Stephanie Hollis A Search For Better Health Topic 11: Epidemiology.
Are exposures associated with disease?
COHORT STUDIES Dr. A. K. AVASARALA MBBS, M.D. PROFESSOR & HEAD DEPT OF COMMUNITY MEDICINE & EPIDEMIOLOGY PRATHIMA INSTITUTE OF MEDICAL SCIENCES, KARIMNAGAR,
Case Control Study Manish Chaudhary BPH, MPH
Cohort Study.
INTRODUCTION TO EPIDEMIOLO FOR POME 105. Lesson 3: R H THEKISO:SENIOR PAT TIME LECTURER INE OF PRESENTATION 1.Epidemiologic measures of association 2.Study.
Multiple Choice Questions for discussion
Dr. Abdulaziz BinSaeed & Dr. Hayfaa A. Wahabi Department of Family & Community medicine  Case-Control Studies.
Case-Control Studies (retrospective studies) Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego.
Estimation of Various Population Parameters Point Estimation and Confidence Intervals Dr. M. H. Rahbar Professor of Biostatistics Department of Epidemiology.
Evidence-Based Medicine 3 More Knowledge and Skills for Critical Reading Karen E. Schetzina, MD, MPH.
CHP400: Community Health Program- lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Case Control Studies Present: Disease Past:
Hypothesis Testing Field Epidemiology. Hypothesis Hypothesis testing is conducted in etiologic study designs such as the case-control or cohort as well.
Lecture 6 Objective 16. Describe the elements of design of observational studies: (current) cohort studies (longitudinal studies). Discuss the advantages.
Measures of Association
ANALYTICAL STUDIES Prospective Studies COHORT Prepared by: Dr. Sahar Sabbour Community Medicine Department.
Cohort Studies, Relative Risk, and Attributable Risk STAT 6395 Spring 2008 Filardo and Ng.
Approaches to the measurement of excess risk 1. Ratio of RISKS 2. Difference in RISKS: –(risk in Exposed)-(risk in Non-Exposed) Risk in Exposed Risk in.
SEARO – CSR Training on Outbreak Investigation Cohort and case-control studies Observational studies.
Cohort design in Epidemiological studies Prof. Ashry Gad Mohamed MBCh B, MPH, DrPH Prof. of Epidemiology Dr Amna R Siddiqui MBBS, MSPH, FCPS, PhD Associate.
Statistics for clinicians Biostatistics course by Kevin E. Kip, Ph.D., FAHA Professor and Executive Director, Research Center University of South Florida,
Measuring the Occurrence of Disease 1 Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State.
S. Mazloomzadeh MD, PhD COHORT STUDIES Learning Objectives To develop an understanding of: - What is a cohort study? - What types of cohort studies are.
RATES AND RISK Daniel E. Ford, MD, MPH Johns Hopkins School of Medicine Introduction to Clinical Research July 12, 2010.
Measures of Association and Impact Michael O’Reilly, MD, MPH FETP Thailand Introductory Course.
Measuring associations between exposures and outcomes
Basic concept of clinical study
COHORT STUDY COHORT A group of people who share a common characteristic or experience within a defined period of time. e.g. age, occupation, exposure.
CHP400: Community Health Program - lI Research Methodology STUDY DESIGNS Observational / Analytical Studies Cohort Study Present: Disease Past: Exposure.
Case Control Studies Dr Amna Rehana Siddiqui Department of Family and Community Medicine October 17, 2010.
Showing Cause, Introduction to Study Design Principles of Epidemiology.
Cohort Studies Dr Hayfa Wahbi, Dr. Amna Rehana Siddiqui & Department of Family & Community Medicine September 2015.
Questions.
Module 6: Part One Analytic Epidemiology: Case-control and cohort study designs.
Case control & cohort studies
Introduction to General Epidemiology (2) By: Dr. Khalid El Tohami.
Chapter 2. **The frequency distribution is a table which displays how many people fall into each category of a variable such as age, income level, or.
Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.
RISK Dr. Kyaw Min MBBS, DTMH, MCTM, MPH, PhD PH FACTM, FRSTMH Lecturer of Tropical Medicine Department of Medicine.
Measures of Association (2) Attributable Risks and fractions October Epidemiology 511 W. A. Kukull.
EPID 503 – Class 12 Cohort Study Design.
Study Designs Group Work
Present: Disease Past: Exposure
Epidemiologic Measures of Association
Epidemiological Methods
بسم الله الرحمن الرحيم COHORT STUDIES.
Study design IV: Cohort Studies
COHORT STUDIES.
Epidemiology MPH 531 Analytic Epidemiology Cohort Studies
Measurements of Risk & Association …
Evaluating Effect Measure Modification
Study design IV: Cohort Studies
Measures of risk and association
Presentation transcript:

Prospective Studies (cohort, longitudinal, incidence studies) Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State University

Prospective Study Design Develop disease Do not develop disease Develop disease Do not develop disease ExposedNot Exposed Population (does not have disease) select

Design Considerations These investigations are oriented to exposure status The objective is to find exposures that lead to disease. How well can you identify exposed individuals? How long should your follow-up be? How frequently do you need to measure exposure? Can you ensure that study subjects do not have the disease at the beginning of the study?

Design Considerations Baseline characteristics of exposed and not exposed subjects should not differ. Use comparable source populations with equivalent information. Both groups should be equally available for follow-up. The degree of surveillance for disease should be equal in both groups. Those assessing for disease should be blind to risk factor group.

Cohort Study Analysis Incidence rate Relative Risk with Confidence Intervals Risk Difference Attributable Risk Population Attributable Risk

The 2 X 2 Table for Cohort Studies a Disease Develops No Disease Exposed (+) Not Exposed (-) b cd Totals a + b c + d First Select

Incidence Rate Incidence Per 1,000 = No. of New Cases of Disease In a Population No. of Persons at Risk of Developing Disease During a Specified Period of Time

Relative Risk Risk of disease among exposed Risk of disease among the not exposed OR Risk (exposed) Incidence (exposed) Risk (unexposed) Incidence (unexposed)

Relative Risk in a 2 X2 Table a DiseaseNo Disease Exposed (+) Not Exposed (-) b cd Risk a c a + b c + d Relative Risk = a/(a+b) c/(c+d)

Relative Risk Relative risk measures the strength of an association The larger the relative risk, the stronger the association between the risk factor and the disease Relative risk does not tell you about the actual risk of the disease (this is measured with incidence)

Etiologic Objective If exposure is associated with disease, the incidence rate in the exposed group will be greater than in the not exposed group. a a + b >>> c c + d Exposed Not exposed

Hypothetical Example: Maternal stress and preterm birth 110 Preterm birth Full term birth Stressed Not stressed 2, ,913 Risk 110 3, ,000 Relative Risk = 110/ /5000 = 2.18 = = 0.017

RR = 1: There is no association between the risk factor and the disease. RR > 1: There is a positive association between the risk factor and the disease. The risk factor may be a cause of disease. Possible range 1 to infinity. RR < 1: There is a negative association between the risk factor and the disease. The risk factor may be protective against the disease. Possible range 0-1. Interpretation of Relative Risk

The Health Risk of Passive Smoking Hirayama et al Study Objective: To assess the health effects of passive cigarette smoking Japan Data collected in 6 prefectures Studied the smoking habits of the spouses of: 91,540 non-smoking wives 20,289 non-smoking husbands

IDENTIFY NEW CASES OF LUNG CANCER Not exposed to second hand smoke PASSIVE SMOKING IN JAPAN 14 YEAR FOLLOW-UP (Death Certificates) Population: Non-smoking spouses Exposed to second hand smoke

Mortality In Non-Smoking Wives Shows increasing risk of mortality with increasing number of cigarettes smoked by spouse Dose-response relationship Relative Risk

Mortality in Non-Smoking Husbands Shows increasing risk of mortality with increasing number of cigarettes smoked by spouse Relative Risk

Exposure to Second Hand Smoke Number Cancers Incidence 15+ cigarettes/day 1, /1, cigarettes/day 1, /1, cigarettes/day 1, /1,000 <5/day 1, /1,000 occasional (not daily) 1, /1,000 quitter 1, /1,000 never smoked 1, /1,000 TOTAL 7, /1,000 Ever smoked 6, /1,000 occasional,quitter,never 3, /1,000 Relative Risk is Relative: Hypothetical Example Relative Risks: 15+ cigarettes/never smoked: 20/2 = Ever smoked/never smoked: 8.5/2 = 4.25 Daily/occasional,quitter,never: 10.8/3.3 = 3.25

The Royal College of General Practitioners (RCGP) Oral Contraception Study England: Is oral contraceptive use a risk factor for cardiovascular disease? May July ,000 oral contraceptive users identified and recruited by physicians Equal number of non-users identified, matched for marital status and age

The RCGP Oral Contraceptive Study ,000 OC Users 23,000 Non- Users Morbidity and Mortality Follow-up

RCGP Oral Contraceptive Study: Relative Risks for Cardiovascular Disease Heart Disease Hypertension Ischemic Heart Disease Subarachnoid Hemorrhage Stroke

The Hepatitis B Virus Cohort Study Taiwan: November 1975 – June 1978 Is Hepatitis B etiologically associated with primary hepatocellular cancer? 21,227 male Taiwanese government civil servants recruited

The Hepatitis B Cohort Study Recruit 22,707 Taiwanese Men ,454 Hepatitis B new cases of primary hepatocellular cancer 19,253 Hepatitis B -

The Hepatitis B Cohort Study 152 Cancer No Cancer HBsAg (+) HBsAg (-) Risk ,253 Relative Risk = 152/3454 9/19,253 = 98.1

Potential Bias in Cohort Studies Bias in Ascertainment of Outcome Staff responsible for the identification of disease are aware of exposure status or hypotheses Diagnostic suspicion bias

Potential Bias in Cohort Studies Information Bias Occurs when the extent or quality of the information obtained is different for exposed and not exposed study subjects.

Potential Bias in Cohort Studies Non-response and Loss to Follow-up Occurs if non-response or loss is different for exposed compared to non- exposed study subjects.

Risk Difference Risk (exposed) Incidence (exposed) Risk (unexposed ) Incidence (unexposed) __

Maternal Stress and Preterm Birth: Risk Difference 110 Preterm birthFull term Stressed Not stressed 2, ,913 Risk 110 3, ,000 Risk difference = = = = The risk of preterm birth is increased by for women who are stressed in their pregnancies

Attributable Risk Percent Risk (exposed) Risk (not exposed ) __ What percent of the risk in the exposed population is due to the exposure? Risk (exposed) X 100

Maternal stress and preterm birth: Attributable risk percent 110 Preterm birthFull term Stressed Not stressed 2, ,913 Risk 110 3, ,000 Attributable risk = X % = = % of the total risk for preterm birth among stressed pregnant women is their stress =

Population Attributable Risk Percent (PARP, Etiologic Fraction) Incidence (total population) Incidence (not exposed) __ The reduction in the incidence of the disease that can be expected if we eliminate the risk factor. X 100 Incidence (total population)

Population Attributable Risk Percent (PARP, Etiologic Fraction) This statistic is influenced by two things: Prevalence of the risk factor in the population The strength of the association between risk factor and disease

Population Attributable Risk Percent (PARP, Etiologic Fraction) Prevalence of the risk factor in the population

Incidence of lung cancer 20% 15% 10% 5% Smokers (25%) Non-smokers (75%) 17% 4% What is the incidence of lung cancer in this population? (17 *.25) + ( 4 *.75) = 7.25% Population Attributable Risk Percent

Incidence of lung cancer 20% 15% 10% 5% Smokers (25%) Non-smokers (75%) 17% 4% Incidence in total pop = 7.25% Among the total population, what is the reduction in incidence that we could expect if we eliminated smoking (exposure) from the population? PAR% = 7.25 X 100 = 44.8% Population Attributable Risk Percent 44.8% of incidence could be reduced if smoking is eliminated

Incidence of lung cancer 20% 15% 10% 5% Smokers (75%) Non-smokers (25%) 17% 4% What if there were far more smokers in the population? Incidence of lung cancer in this population = (17*.75) + (4*.25) = 13.75% PAR% = X 100 = 70.9% Population Attributable Risk Percent 70.9% of incidence could be reduced if smoking is eliminated

Population Attributable Risk Percent (PARP, Etiologic Fraction) The strength of the association between the risk factor and the disease

Incidence of lung cancer 20% 15% 10% 5% Smokers (75%) Non-smokers (25%) 10% 4% What if there were just as many smokers but they smoked less? (only 2 cigarettes per day each) Incidence of lung cancer in this population = (10*.75) + (4*.25) = 8.5% PAR% = X 100 = 52.9% Population Attributable Risk Percent 52.9% of incidence could be reduced if smoking is eliminated

Population Attributable Risk Percent: A comparison of three populations PARP = Incidence in population - incidence in not exposed (incidence of lung cancer in not Incidence in population exposed is 4%) Pop #1: Total population incidence = (.25*17) + (.75*4) = 7.25% 25% smokers PARP = 7.25 – 4 = 44.8% 17% cancer incidence 7.25 Pop #2: Total population incidence = (.75*17) + (.25*4) = 13.75% 75% smokers PARP = – 4 = 70.9% 17% cancer incidence Pop #3: Total population incidence = (.75*10) + (.25*4) = 8.5% 75% smokers PARP = 8.5 – 4 = 52.9% Only 2 a day % cancer incidence